Is There a Role for Detection of Complement-Binding Antibodies in Kidney Transplantation? Jayme E. Locke, MD, MPH American Journal of Kidney Diseases Volume 63, Issue 4, Pages 558-560 (April 2014) DOI: 10.1053/j.ajkd.2014.01.007 Copyright © 2014 National Kidney Foundation, Inc. Terms and Conditions
Figure 1 The impact of donor-specific antibodies on long-term kidney transplant survival. Complement-binding (C1q) donor-specific anti-HLA antibodies (DSAs) are associated with significantly lower transplant survival compared with non–C1q-binding DSAs or the absence of DSAs. American Journal of Kidney Diseases 2014 63, 558-560DOI: (10.1053/j.ajkd.2014.01.007) Copyright © 2014 National Kidney Foundation, Inc. Terms and Conditions